1. 1

    Do not order herpes serology tests unless there is a clear clinical indication

    Evidence

       

    Guerry SL, Bauer HM, Klausner JD, Branagan B, Kerndt, PR. Recommendations for the selective use of herpes simplex virus type 2 serological tests. Clinical Infectious Diseases 2005; 40(1): 38-45

    New Zealand Herpes Foundation. Guidelines for the Management of Genital Herpes in New Zealand. 10th Ed, 2013

    Scoular A. Using the evidence base on genital herpes: optimising the use of diagnostic tests and information provision. Sexually Transmitted Infections 2002; 78(3): 160–165

    Strick L, Wald A. Type specific testing for herpes simplex virus. Expert Review of Molecular Diagnostics 2004; 4: 443-53

  2. 2

    Do not screen for chlamydia using serological tests  

  3. 3

    Do not treat recurrent or persistent symptoms of vulvovaginal candidiasis with topical and oral anti-fungal agents without further clinical and microbiological assessment

  4. 4

    Do not test for ureaplasma species in asymptomatic patients    

  5. 5

    Reconsider the use of nucleic acid amplification testing for gonorrhoea in low-prevalence (i.e. <1% prevalence) populations and people who do not belong to a higher risk group